ICU End Period Cash Flow vs Change To Inventory Analysis
ICUI Stock | USD 106.34 2.81 2.71% |
ICU Medical financial indicator trend analysis is infinitely more than just investigating ICU Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ICU Medical is a good investment. Please check the relationship between ICU Medical End Period Cash Flow and its Change To Inventory accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.
End Period Cash Flow vs Change To Inventory
End Period Cash Flow vs Change To Inventory Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ICU Medical End Period Cash Flow account and Change To Inventory. At this time, the significance of the direction appears to have almost no relationship.
The correlation between ICU Medical's End Period Cash Flow and Change To Inventory is 0.14. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Change To Inventory in the same time period over historical financial statements of ICU Medical, assuming nothing else is changed. The correlation between historical values of ICU Medical's End Period Cash Flow and Change To Inventory is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of ICU Medical are associated (or correlated) with its Change To Inventory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Inventory has no effect on the direction of End Period Cash Flow i.e., ICU Medical's End Period Cash Flow and Change To Inventory go up and down completely randomly.
Correlation Coefficient | 0.14 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
End Period Cash Flow
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Most indicators from ICU Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ICU Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.As of now, ICU Medical's Enterprise Value Multiple is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 491.5M | 697.8M | 709.8M | 745.3M | Total Revenue | 1.3B | 2.3B | 2.3B | 2.4B |
ICU Medical fundamental ratios Correlations
Click cells to compare fundamentals
ICU Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ICU Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.7B | 1.8B | 1.9B | 4.5B | 4.4B | 4.6B | |
Other Current Liab | 105.8M | 109.3M | 98.0M | 218.1M | 228.1M | 239.6M | |
Total Current Liabilities | 248.5M | 195.5M | 200.8M | 494.6M | 481.8M | 505.9M | |
Total Stockholder Equity | 1.4B | 1.5B | 1.6B | 2.1B | 2.1B | 2.2B | |
Property Plant And Equipment Net | 490.6M | 513.2M | 508.2M | 711.0M | 682.8M | 717.0M | |
Net Debt | (232.4M) | (344.0M) | (507.8M) | 1.4B | 1.5B | 1.5B | |
Retained Earnings | 721.8M | 808.7M | 911.8M | 837.5M | 807.8M | 848.2M | |
Accounts Payable | 128.6M | 71.9M | 81.1M | 215.9M | 150.0M | 157.5M | |
Cash | 268.7M | 396.1M | 552.8M | 208.8M | 254.2M | 137.4M | |
Non Current Assets Total | 810.2M | 842.9M | 850.9M | 3.3B | 3.2B | 3.3B | |
Non Currrent Assets Other | 49.0M | 55.5M | 63.7M | 105.5M | 56.4M | 59.2M | |
Cash And Short Term Investments | 292.6M | 410.8M | 567.2M | 213.0M | 254.7M | 178.0M | |
Net Receivables | 202.2M | 124.1M | 105.9M | 221.7M | 164.3M | 172.5M | |
Common Stock Shares Outstanding | 21.5M | 21.6M | 21.8M | 23.9M | 24.1M | 17.2M | |
Liabilities And Stockholders Equity | 1.7B | 1.8B | 1.9B | 4.5B | 4.4B | 4.6B | |
Inventory | 337.6M | 314.9M | 290.2M | 696.0M | 709.4M | 744.8M | |
Other Stockholder Equity | 668.8M | 693.0M | 721.4M | 1.3B | 1.4B | 1.4B | |
Total Liab | 315.1M | 261.4M | 264.7M | 2.4B | 2.3B | 2.4B | |
Property Plant And Equipment Gross | 490.6M | 513.2M | 468.4M | 711.0M | 1.3B | 1.4B | |
Total Current Assets | 882.2M | 920.8M | 1.0B | 1.2B | 1.2B | 1.3B | |
Accumulated Other Comprehensive Income | (15.4M) | (1.5M) | (19.3M) | (81.0M) | (53.1M) | (50.4M) | |
Non Current Liabilities Total | 66.7M | 65.9M | 63.9M | 1.9B | 1.8B | 1.9B | |
Other Current Assets | 4.4M | 1.8M | 2.2M | 88.9M | 91.2M | 95.8M | |
Intangible Assets | 211.4M | 197.2M | 188.3M | 982.8M | 870.6M | 914.1M | |
Common Stock Total Equity | 2.0M | 2.1M | 2.1M | 2.1M | 2.4M | 1.7M | |
Short Term Investments | 24.0M | 14.7M | 14.4M | 4.2M | 501K | 476.0K | |
Common Stock | 2.1M | 2.1M | 2.1M | 2.4M | 2.4M | 1.8M | |
Other Assets | 77.0M | 146.1M | 106.3M | 104.4M | 120.1M | 126.1M | |
Treasury Stock | (95K) | (157K) | (39K) | (27K) | (31.1K) | (32.6K) | |
Property Plant Equipment | 456.1M | 466.6M | 468.4M | 713.6M | 820.6M | 861.6M | |
Other Liab | 37.8M | 18.1M | 22.1M | 244.7M | 281.4M | 295.5M | |
Net Tangible Assets | 1.2B | 1.3B | 1.6B | (342.1M) | (393.4M) | (373.7M) | |
Current Deferred Revenue | 6.7M | 5.6M | 12.6M | 30.8M | 31.6M | 33.2M | |
Good Will | 31.2M | 33.0M | 43.4M | 1.4B | 1.5B | 1.5B | |
Retained Earnings Total Equity | 620.7M | 721.8M | 808.7M | 911.8M | 1.0B | 553.4M | |
Capital Surpluse | 657.9M | 668.9M | 693.1M | 721.4M | 829.6M | 871.1M | |
Deferred Long Term Liab | 2.1M | 1.7M | 1.5M | 5.2M | 4.6M | 2.7M | |
Long Term Investments | 0.0 | 13.0M | 4.6M | 3.7M | 3.1M | 4.2M | |
Non Current Liabilities Other | 47.3M | 64.3M | 62.4M | 54.4M | 33.9M | 27.4M |
Currently Active Assets on Macroaxis
When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ICU Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is ICU Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (2.45) | Revenue Per Share 93.49 | Quarterly Revenue Growth (0) | Return On Assets 0.0048 |
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.